Why do I have man boobs after taking testosterone?

Testosterone therapy can paradoxically cause gynecomastia (man boobs) when excess testosterone converts to estrogen through aromatization. Managing this requires balancing hormones through proper dosing, aromatase inhibitors, or lifestyle changes.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding the Testosterone-Estrogen Connection

If you've started testosterone replacement therapy (TRT) expecting to build muscle and enhance masculine characteristics, developing breast tissue might feel like a cruel irony. This condition, medically known as gynecomastia, affects between 10-25% of men on testosterone therapy. The paradox lies in how your body processes the very hormone you're supplementing.

When you introduce external testosterone into your system, your body doesn't simply use it all for masculine effects. Through a process called aromatization, an enzyme called aromatase converts some of that testosterone into estradiol, the primary form of estrogen. This conversion happens naturally in fat tissue, the liver, and even in the brain. The more testosterone you have circulating, the more raw material is available for conversion to estrogen.

This biological process evolved as a balancing mechanism. Your body maintains hormone homeostasis through complex feedback loops, and when it detects high testosterone levels, it may increase aromatase activity to maintain what it perceives as balance. Unfortunately, this can lead to estrogen levels that are too high relative to testosterone, triggering the growth of breast tissue. Regular monitoring of your hormone levels can help identify these imbalances before they become problematic.

Stages of Gynecomastia Development

Early detection and intervention significantly improve treatment outcomes and reversibility.
StageDurationPhysical SignsReversibility
Stage 1Initial/Inflammatory0-6 monthsNipple tenderness, small lumps behind nippleHighly reversible with treatment
Stage 2Proliferative6-12 monthsVisible breast bud, puffy nipples, soft tissuePartially reversible with medication
Stage 3Fibrous>12 monthsFirm breast tissue, visible enlargementRarely reversible without surgery
Stage 4Established>2 yearsSignificant breast development, excess skinRequires surgical correction

Early detection and intervention significantly improve treatment outcomes and reversibility.

The Role of Aromatase Activity

Aromatase activity varies significantly between individuals based on genetics, body composition, and age. Men with higher body fat percentages typically have more aromatase enzyme activity because fat tissue is a primary site of estrogen production. This explains why overweight men on TRT are more likely to develop gynecomastia. Additionally, certain genetic variations can make some men naturally high aromatizers, meaning they convert testosterone to estrogen more efficiently than others.

Types and Stages of Gynecomastia

Gynecomastia from testosterone therapy typically develops in stages, and understanding these can help you identify the condition early. The progression usually follows a predictable pattern that correlates with hormone imbalances.

Early Warning Signs

The earliest signs often include nipple sensitivity or tenderness, which many men initially dismiss as a side effect of working out or clothing irritation. You might notice a burning or tingling sensation around the nipple area, particularly when touched or during temperature changes. Some men report feeling small, firm lumps directly behind the nipple, which represent the beginning of glandular tissue development.

As the condition progresses, you may notice visible changes such as puffy or protruding nipples, even when cold. The areola may appear enlarged or darker, and the chest area might feel fuller or softer than usual. These changes can occur in one or both breasts, with unilateral gynecomastia being surprisingly common in the early stages.

Risk Factors Beyond Aromatization

While aromatization is the primary mechanism, several factors can increase your risk of developing gynecomastia on testosterone therapy. Understanding these can help you and your healthcare provider develop a more effective treatment strategy.

Dosing and Administration Issues

Higher testosterone doses don't always mean better results, and they significantly increase the risk of estrogen-related side effects. Men who take supraphysiological doses, whether prescribed or self-administered, provide more substrate for aromatization. The method of administration also matters: injectable testosterone often causes more dramatic peaks and valleys in hormone levels compared to gels or patches, potentially triggering more aromatase activity during peak periods.

Injection frequency plays a crucial role as well. Less frequent, larger injections create more pronounced hormonal fluctuations, which can stimulate aromatase expression. Many clinicians now recommend more frequent, smaller injections to maintain steadier hormone levels and reduce the risk of estrogen-related side effects.

Concurrent Medications and Supplements

Certain medications can exacerbate gynecomastia risk when combined with testosterone therapy. Human chorionic gonadotropin (hCG), often prescribed alongside TRT to maintain testicular function, can increase intratesticular aromatase activity. Some antidepressants, particularly SSRIs, may affect hormone metabolism and increase prolactin levels, another hormone that can contribute to breast tissue growth.

Even seemingly harmless supplements can play a role. Some herbal products contain phytoestrogens or compounds that affect hormone metabolism. Alcohol consumption, particularly heavy drinking, can impair liver function and affect estrogen clearance, worsening the hormone imbalance.

Prevention Strategies and Treatment Options

Preventing gynecomastia is generally easier than treating established breast tissue, making proactive management essential. The key lies in maintaining optimal hormone ratios rather than simply maximizing testosterone levels.

Pharmaceutical Interventions

Aromatase inhibitors (AIs) like anastrozole or exemestane can effectively reduce estrogen production by blocking the aromatase enzyme. However, these medications require careful monitoring as completely suppressing estrogen can lead to joint pain, mood changes, and cardiovascular risks. The goal is to find the minimum effective dose that prevents gynecomastia while maintaining some estrogen for its beneficial effects on bone health, libido, and cardiovascular function.

Selective estrogen receptor modulators (SERMs) like tamoxifen work differently by blocking estrogen receptors in breast tissue while allowing estrogen to work elsewhere in the body. This approach can be particularly effective for treating early-stage gynecomastia or preventing its progression. Some men use SERMs prophylactically when starting TRT, especially if they have risk factors for gynecomastia.

Lifestyle Modifications

Weight loss can significantly reduce aromatase activity by decreasing the amount of fat tissue available for estrogen production. Even a 10-15% reduction in body weight can meaningfully impact hormone balance. Combining testosterone therapy with a structured diet and exercise program not only reduces gynecomastia risk but also enhances the overall benefits of treatment.

Dietary choices matter too. Cruciferous vegetables like broccoli, cauliflower, and Brussels sprouts contain compounds that support healthy estrogen metabolism. Limiting alcohol intake, particularly beer which contains hops (a phytoestrogen), can help maintain better hormone balance. Some men find that reducing dairy consumption helps, as commercial dairy products may contain trace amounts of hormones.

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

Monitoring and Testing Protocols

Regular hormone monitoring is crucial for preventing and managing gynecomastia on testosterone therapy. Baseline testing before starting TRT provides important reference points, while follow-up testing helps optimize your protocol and catch problems early.

Essential biomarkers to monitor include total testosterone, free testosterone, estradiol (using a sensitive assay), and sex hormone-binding globulin (SHBG). The testosterone-to-estradiol ratio is particularly important, with most men feeling best when this ratio falls between 14:1 and 20:1. Additional markers like prolactin, DHT, and liver function tests can provide valuable context for troubleshooting hormone imbalances. Understanding your complete hormone profile through comprehensive testing allows for more precise adjustments to your treatment protocol.

Testing frequency depends on your individual response and stability on treatment. During the initial optimization phase, testing every 6-8 weeks allows for timely adjustments. Once stable, quarterly testing is typically sufficient, though any new symptoms warrant immediate evaluation. Some men benefit from using at-home testing services between doctor visits to track trends and catch changes early.

When Surgery Becomes Necessary

Despite optimal medical management, some men develop fibrous breast tissue that won't respond to hormone optimization or medication. Gynecomastia present for more than 12 months rarely resolves without surgical intervention, as the glandular tissue becomes increasingly fibrous over time.

Surgical options range from liposuction for primarily fatty tissue to direct glandular excision for fibrous tissue. Many plastic surgeons use a combination approach, removing glandular tissue through a small periareolar incision while using liposuction to contour the surrounding area. Recovery typically takes 4-6 weeks, with most men returning to normal activities within 2-3 weeks.

The decision for surgery should consider both physical and psychological factors. While gynecomastia isn't dangerous, its impact on self-esteem and quality of life can be significant. Many men report improved confidence and satisfaction with their TRT results after surgical correction. However, it's crucial to optimize hormone levels before surgery to prevent recurrence.

Long-term Management and Optimization

Successfully managing testosterone therapy without developing gynecomastia requires a personalized, dynamic approach. What works initially may need adjustment as your body composition changes, you age, or your lifestyle evolves. The goal isn't just to prevent gynecomastia but to optimize your overall hormone balance for maximum benefit with minimal side effects.

Working with an experienced hormone specialist who understands the nuances of TRT management is invaluable. They can help you navigate the complex interplay between testosterone, estrogen, and other hormones while considering your individual goals and risk factors. Regular communication about symptoms, even subtle ones, allows for proactive adjustments before problems become established.

Remember that developing gynecomastia doesn't mean testosterone therapy has failed or that you need to stop treatment. In most cases, adjusting your protocol, adding appropriate medications, or addressing lifestyle factors can resolve the issue while maintaining the benefits of optimized testosterone levels. The key is early recognition, appropriate intervention, and ongoing monitoring to maintain the delicate hormone balance your body needs.

For those considering or currently on testosterone therapy, understanding the relationship between testosterone and estrogen empowers you to make informed decisions about your treatment. By staying vigilant for early signs, maintaining open communication with your healthcare provider, and following a comprehensive monitoring protocol, you can maximize the benefits of TRT while minimizing the risk of unwanted side effects like gynecomastia. If you're interested in understanding your complete hormone profile and how it might be affecting your body composition and overall health, consider getting a comprehensive hormone panel that includes all the relevant markers. You can also take advantage of SiPhox Health's free blood test analysis service to get personalized insights from your existing lab results.

References

  1. Rahnema, C. D., Lipshultz, L. I., Crosnoe, L. E., Kovac, J. R., & Kim, E. D. (2014). Anabolic steroid-induced hypogonadism: diagnosis and treatment. Fertility and Sterility, 101(5), 1271-1279.[Link][DOI]
  2. Gruntmanis, U., & Braunstein, G. D. (2001). Treatment of gynecomastia. Current Opinion in Investigational Drugs, 2(5), 643-649.[PubMed]
  3. Kanakis, G. A., Nordkap, L., Bang, A. K., Calogero, A. E., Bártfai, G., Corona, G., et al. (2019). EAA clinical practice guidelines-gynecomastia evaluation and management. Andrology, 7(6), 778-793.[Link][DOI]
  4. Rhoden, E. L., & Morgentaler, A. (2004). Risks of testosterone-replacement therapy and recommendations for monitoring. New England Journal of Medicine, 350(5), 482-492.[PubMed][DOI]
  5. Dickson, G. (2012). Gynecomastia. American Family Physician, 85(7), 716-722.[Link][PubMed]
  6. de Ronde, W., & de Jong, F. H. (2011). Aromatase inhibitors in men: effects and therapeutic options. Reproductive Biology and Endocrinology, 9, 93.[Link][PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my testosterone and estrogen levels at home?

You can test your testosterone and estrogen at home with SiPhox Health's Hormone Focus Program. This CLIA-certified program includes comprehensive hormone testing including testosterone, free testosterone, estradiol, SHBG, and other key markers, providing lab-quality results from the comfort of your home.

How long does it take for gynecomastia to develop after starting testosterone?

Gynecomastia can develop within weeks to months after starting testosterone therapy, depending on individual factors like dosing, aromatase activity, and body composition. Early signs like nipple sensitivity may appear within 2-4 weeks, while visible tissue changes typically occur after 2-3 months of elevated estrogen levels.

Can gynecomastia from testosterone therapy go away on its own?

Early-stage gynecomastia (less than 6 months) may resolve with hormone optimization, medication, or dosage adjustments. However, established fibrous tissue present for over 12 months rarely resolves without surgical intervention. Early detection and treatment significantly improve the chances of non-surgical resolution.

What is the ideal testosterone to estradiol ratio to prevent gynecomastia?

Most men feel best and avoid gynecomastia when their testosterone-to-estradiol ratio falls between 14:1 and 20:1. However, individual optimal ratios vary based on genetics and sensitivity to hormones. Regular monitoring helps identify your personal sweet spot for hormone balance.

Should I stop testosterone therapy if I develop gynecomastia?

Stopping testosterone therapy isn't usually necessary. Most cases can be managed by adjusting your dose, changing injection frequency, adding an aromatase inhibitor or SERM, or addressing lifestyle factors. Work with your healthcare provider to modify your protocol rather than discontinuing treatment entirely.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details